Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AM.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.258.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.20NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.36.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.37NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.319NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.318NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.557NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.557NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.119NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.160NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.160NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
D.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.447NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.447NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.589NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.589NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.335NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.169NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.43NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.42NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.423NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.281NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.281NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.230NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.230NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.535NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.535NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
A.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
A.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.564.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.564.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.345NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.345NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23143.5US
B.1.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.53NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used